Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 26,292
Sort by:

Radiologic Cancer Therapy - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Radiologic Cancer Therapy - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...

January 2022 60 pages

Radiotherapy induced Oral Mucositis - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Radiotherapy induced Oral Mucositis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of...

January 2022 60 pages

Rare NRG1 Fusion -Epidemiology Forecast -2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Rare NRG1 Fusion - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...

January 2022 60 pages

Rare NRG1 Fusion - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Rare NRG1 Fusion- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understan...

January 2022 200 pages

Reactive Airway Disease - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Reactive Airway Disease - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...

January 2022 60 pages

Reactive Airway Disease - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Reactive Airway Disease- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth un...

January 2022 200 pages

Reactive Arthritis - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Reactive Arthritis- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth underst...

January 2022 200 pages

Recessive Dystrophic Epidermolysis - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Recessive Dystrophic Epidermolysis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of...

January 2022 60 pages

Recessive Dystrophic Epidermolysis - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Recessive Dystrophic Epidermolysis- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an...

January 2022 200 pages

Recurrent blood clots (Thrombophilia) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Recurrent blood clots (Thrombophilia)- Market Insights, Epidemiology, and Market Forecast-2032' report delivers...

January 2022 200 pages

Recurrent Clostridioides Difficile Infection (rCDI) - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Recurrent Clostridioides Difficile Infection (rCDI) - Epidemiology Forecast to 2032' report delivers an in-depth...

January 2022 60 pages

Recurrent Glioblastoma - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Recurrent Glioblastoma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...

January 2022 60 pages

Recurrent Glioblastoma - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Recurrent Glioblastoma- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth und...

January 2022 200 pages

Recurrent Herpes Labialis - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Recurrent Herpes Labialis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...

January 2022 60 pages

Recurrent Herpes Labialis - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Recurrent Herpes Labialis- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth...

January 2022 200 pages

Recurrent Malignant Glioma - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Recurrent Malignant Glioma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dise...

January 2022 60 pages

Recurrent Malignant Glioma - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Recurrent Malignant Glioma- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth...

January 2022 200 pages

Recurrent or Metastatic Head and Neck cancer - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Recurrent or Metastatic Head and Neck cancer - Epidemiology Forecast to 2032' report delivers an in-depth underst...

January 2022 60 pages

Recurrent or Metastatic Head and Neck cancer - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Recurrent or Metastatic Head and Neck cancer- Market Insights, Epidemiology, and Market Forecast-2032' report de...

January 2022 200 pages

Recurrent or Metastatic HER2-Overexpressing Solid Tumors - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Recurrent or Metastatic HER2-Overexpressing Solid Tumors - Epidemiology Forecast to 2032' report delivers an in-d...

January 2022 60 pages

Recurrent or Metastatic Nasopharyngeal Carcinoma - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Recurrent or Metastatic Nasopharyngeal Carcinoma - Epidemiology Forecast to 2032' report delivers an in-depth und...

January 2022 60 pages

Recurrent Pericarditis - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Recurrent Pericarditis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...

January 2022 60 pages

Recurrent Pericarditis - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Recurrent Pericarditis- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth und...

January 2022 200 pages

Refractive Errors - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Refractive Errors - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...

January 2022 60 pages

Refractory Angina - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Refractory Angina- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understa...

January 2022 200 pages

Refractory Epilepsy - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Refractory Epilepsy - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...

January 2022 60 pages

Refractory Epilepsy - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Refractory Epilepsy- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth unders...

January 2022 200 pages

Refractory Metastatic Melanoma - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Refractory Metastatic Melanoma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the...

January 2022 60 pages

Refractory Metastatic Melanoma - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Refractory Metastatic Melanoma- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-d...

January 2022 200 pages

Refractory Multiple Myeloma - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Refractory Multiple Myeloma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dis...

January 2022 60 pages

Refractory Multiple Myeloma - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Refractory Multiple Myeloma- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-dept...

January 2022 200 pages

Refractory Status Epilepticus (RSE) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Refractory Status Epilepticus (RSE) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of...

January 2022 60 pages

Refractory Status Epilepticus (RSE) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Refractory Status Epilepticus (RSE)- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an...

January 2022 200 pages

Relapsed B-Cell Small Lymphocytic Lymphoma - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Relapsed B-Cell Small Lymphocytic Lymphoma - Epidemiology Forecast to 2032' report delivers an in-depth understan...

January 2022 60 pages

relapsed and refractory CD5-expressing T cell lymphomas - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'relapsed and refractory CD5-expressing T cell lymphomas - Epidemiology Forecast to 2032' report delivers an in-de...

January 2022 60 pages

Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) - Epidemiology Forecast to 2032' report delivers an in-...

January 2022 60 pages

Relapsed or Refractory Mycosis Fungoides - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Relapsed or Refractory Mycosis Fungoides - Epidemiology Forecast to 2032' report delivers an in-depth understandi...

January 2022 60 pages

Relapsed or Refractory Mycosis Fungoides - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Relapsed or Refractory Mycosis Fungoides- Market Insights, Epidemiology, and Market Forecast-2032' report delive...

January 2022 200 pages

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) - Epidemiology Forecast to 2032' report delivers an in-depth...

January 2022 60 pages

relapsed/refractory Epstein-Barr virus (EBV) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'relapsed/refractory Epstein-Barr virus (EBV) - Epidemiology Forecast to 2032' report delivers an in-depth underst...

January 2022 60 pages

Relapsed/Refractory Epstein Barr Virus - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Relapsed/Refractory Epstein Barr Virus - Epidemiology Forecast to 2032' report delivers an in-depth understanding...

January 2022 60 pages

Relapsed/Refractory Epstein Barr Virus - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Relapsed/Refractory Epstein Barr Virus- Market Insights, Epidemiology, and Market Forecast-2032' report delivers...

January 2022 200 pages

relapsed/refractory (R/R) Epstein-Barr virus (EBV) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'relapsed/refractory (R/R) Epstein-Barr virus (EBV)- Market Insights, Epidemiology, and Market Forecast-2032' rep...

January 2022 200 pages

Relapsing Refractory Multiple Myeloma - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Relapsing Refractory Multiple Myeloma - Epidemiology Forecast to 2032' report delivers an in-depth understanding...

January 2022 60 pages

Relapsing Refractory Multiple Myeloma - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Relapsing Refractory Multiple Myeloma- Market Insights, Epidemiology, and Market Forecast-2032' report delivers...

January 2022 200 pages

REM poisioning - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'REM poisioning - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histori...

January 2022 60 pages

REM Sleep Behavior Disorder - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'REM Sleep Behavior Disorder - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dis...

January 2022 60 pages

REM Sleep Behavior Disorder - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'REM Sleep Behavior Disorder- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-dept...

January 2022 200 pages

Renal Fanconi Syndrome - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Renal Fanconi Syndrome- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth und...

January 2022 200 pages

Renal Impairment - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Renal Impairment - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...

January 2022 60 pages

Filters

Search

Categories

116
13,944
10,874
309
72
977

Publishers

72
1
342
469
292
33
4
1,872
635
92
3,109
8
109
111
554
7
55
5
5
6
23
18
23
205
30
34
6,128
13
12
142
363
8
25
84
385
8
14
49
179
7
2,002
139
579
2,786
7
24
44
31
54
61
7
2,538
40
34
11
22
16
38
2
4
83
4
26
50
1
139
11
118
36
20
61
32
50
33
27
32
42
326
877
49
88
80
59
37
2
14
22
2

Regions

8
7
7
7
7
7
7
6
6
5
3
2
2
1
1
1
247
59
50
48
47
46
42
27
22
22
19
18
17
16
15
15
15
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
11
11
11
11
11
10
10
10
10
10
9
9
9
7
6
6
5
184
13
12
8
431
235
126
56
49
33
29
8
7
6
6
6
6
6
5
5
5
4
3
3
5
5
5
4
3
1
1
1
1
1
2
2
77
23,687

Price

—

Date

—

Pages

—

Offers

44
5
1